Off Patent
June 2027

Lumigan

bimatoprost

Abbvie Inc

Solution/drops (ophthalmic) · NDA 022184

Last listed protection ends
June 13, 2027

The FDA lists 1 patent for Lumigan, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,851,504
    Claims the drug substance and the drug product